Tag Archives: KNOP

Hot Biotech Stocks For 2019

It would be fair to say biotech has had an interesting time of it over the course of the past 15 months. Except, of course, that biotech always has an interesting time of it. The go big or go home sector of the market attracts speculators, scientists, and unsavory characters, but also attracts people hoping for critical improvements to their healthcare options.

With a lot of sentiment and sometimes too little information, it can be hard to find an edge. Throw in the political questions stemming from stories like Valeant (NYSE:VRX), Sarepta (NASDAQ:SRPT), and Mylan (NASDAQ:MYL), and the interesting times don’t appear likely to go away.

With an assist from SA Managing Editor (and CFA) Mike Taylor, we asked a few authors who focus on the biotech sector to tell us which way they think the winds might blow.

Our panel:

Bret Jensen, author of The Biotech Forum ONeil Trader, author of Growth Stock Forum Bhavneesh Sharma, author of Vasuda Healthcare Analytics Chris Lau, author of Value Stocks for DIY Investors Alexander J. Poulos, author of Undervalued Gems Wall Street Titan, author of Stem Cell Sector News and Analysis

Seeking Alpha: Investors are aware of headline political risk this year, but there’s also some regulator level confusion. On one hand, we have a recent approval decision on a six-figure drug from Sarepta with controversy over efficacy, to put it mildly. On the other hand, there’s uproar over the EpiPen, which some argue is expensive but at least is acknowledged to work. How are you evaluating the FDA’s and regulators’ posture relative to industry?

Hot Biotech Stocks For 2019: KNOT Offshore Partners LP(KNOP)

Advisors’ Opinion:

  • [By ]

    If I Could Only Choose One…
    Of all the double-digit yielders in my screening universe, Knot Offshore Partners (NYSE: KNOP) has the strongest coverage ratio. The company is currently distributing annual payments of $2.08 per share, and the average earnings estimate for next year is $2.51 per share — for a comfortable coverage ratio of 121% ($2.51/$2.08).

Hot Biotech Stocks For 2019: Evoke Pharma, Inc.(EVOK)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
    Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
    Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
    Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
    Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
    Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
    Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
    Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
    OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
    Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
    Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
    Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo

  • [By Cameron Saucier]

    Evoke (Nasdaq: EVOK) is a pharmaceutical company that develops drug candidates intended to treat gastrointestinal diseases. EVOK rose 73% last month after it announced positive guidance from the FDA for Gimoti, a patented nasal delivery drug that is intended to treat gastroparesis in adult women. The positive results were from a second pre-NDA (New Drug Application) meeting Evoke had with the FDA. EVOK is currently trading at $2.67 per share and is down 9.83% as of Jan. 9 YOY.

Hot Biotech Stocks For 2019: Oxford Industries Inc.(OXM)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Looking at recent historical deals, we arrive at a $18-$23 potential deal range. We analyzed transactions that have been announced over the past four years and involved companies catering to a higher income customer. These deals include Southern Tide (acquired by Oxford Industries (OXM)), Joe’s Jeans (acquired by Sequential Brands Group (SQBG)), prAna (acquired by Columbia Sportswear (COLM)), The Jones Group (acquired by Sycamore Partners [private] and Juicy Couture (acquired by Authentic Brands Group [private]). The average EV/EBITDA multiple of these transactions are 12.9x (in line with KATE’s 5-year historical average of 12.1x) and implies a potential deal range of $22-$23. When taking the average of recent (F13-16) deals implies an ~10.5x EV/EBITDA multiple. When applying the ~10.5x multiples to KATE’s trailing EBITDA, we arrive at an $18- $19 potential share price.

  • [By Lisa Levin]

    Oxford Industries Inc (NYSE: OXM) was down, falling around 11 percent to $64.05. Oxford Industries reported a narrower-than-expected loss for its third quarter. The company projects full-year earnings of $3.50 to $3.65 per share, and revenue of $1.02 billion to $1.03 billion.

best it stocks

The post-Thanksgiving IPO market got off to a slower start than expected, with just one company raising $67 million, no filings and three launches this week, including Apollo-backed fixed-annuity provider Athene Holding, fluid subsystem delivery provider Ichor Holdings and Texas- and Louisiana-based E&P Wildhorse Resource Development. While Wildhorse launched its IPO just one day after OPEC reached a deal to cut production, we believe that most other JOBS act companies will wait to file, as it is too late for them to launch an IPO in 2016.

At the start of December, the average 2016 US IPO is up 26%, and 72% of IPOs are trading above their offer price, compared to one year ago, when just 44% of IPOs were trading above their offer price

IPO Pricings Week of November 28th, 2016 Issuer
Business Deal Size
($mm) Market Cap
($mm) Price vs.
midpoint First day
return Return
at 12/2 Innovative Industrial Properties REIT
REIT focused on medical-use marijuana $67 $68 0% -4.3% -7.8% Click to enlarge

Up in smoke: Marijuana REIT cuts deal multiple times to complete IPO
Innovative Industrial Products REIT (Pending:IIPR), a newly-formed REIT focused on medical-use cannabis cultivation facilities, raised $67 million by offering 3.35 million shares at $20; however, the pricing came after multiple updated filings, which both eliminated shares to be offered to management at no cost and slashed the deal size from $175 million to $80 million, before it further downsized the offering at the pricing. The IPO came at a tough time for REITs, as rates are widely expected to be raised at the December meeting of the Fed. Despite an experienced management team and the recent legalization of recreational marijuana in multiple states, the company faces increased scrutiny due to the dubious federal legal status of marijuana cultivation and production. The company traded off 4% on its first day and closed week down

best it stocks: ArQule Inc.(ARQL)

Advisors’ Opinion:

  • [By Paul Ausick]

    ArQule Inc. (NASDAQ: ARQL) dropped about 23% Friday, to post a new 52-week low of $1.13 after closing at $1.47 on Thursday. The stock’s 52-week high is $2.17. Volume was about 15 times the daily average of around 150,000 shares. The biopharmaceutical company said this morning that a phase 3 trial of a cancer drug did not meet the primary endpoint of improving overall survival.

best it stocks: Celanese Corporation(CE)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Time To Favor Optionality: Most macro data are similar to, or better than, when the merger was announced. As a result, the same returns have been obtainable, with significantly less stress, simply through owning 3M (MMM) or a basket of chemical companies that approximate the Dow-DuPont portfolio. Relative to the chemical sector, performance has been average, leverage appears reasonable but near-term FCF less-than compelling partly due to new capacity ramping. With the merger likely to close in the near-term (90% chance, in our view), we believe Dow-DuPont will have an opportunity to show how scale creates optionality. The overhaul at Celanese (CE) over the past few years shows the way.

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Albemarle Corporation (NYSE: ALB): Free Stock Analysis Report
     
    Celanese Corporation (NYSE: CE): Free Stock Analysis Report
     
    Kronos Worldwide Inc (NYSE: KRO): Free Stock Analysis Report
     
    Koppers Holdings Inc. (NYSE: KOP): Free Stock Analysis Report
     
    Chemours Company (The) (CC): Free Stock Analysis Report
     
    Kraton Corporation (NYSE: KRA): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

best it stocks: KNOT Offshore Partners LP(KNOP)

Advisors’ Opinion:

  • [By ]

    If I Could Only Choose One…
    Of all the double-digit yielders in my screening universe, Knot Offshore Partners (NYSE: KNOP) has the strongest coverage ratio. The company is currently distributing annual payments of $2.08 per share, and the average earnings estimate for next year is $2.51 per share — for a comfortable coverage ratio of 121% ($2.51/$2.08).

best it stocks: CNO Financial Group, Inc.(CNO)

Advisors’ Opinion:

  • [By Paul Ausick]

    CNO Financial Group Inc. (NYSE: CNO) dropped about 8.1% on Friday to post a new 52-week low of $14.29 against a 52-week high of $20.88. Volume of more than 6 million was more than 3 times the daily average of around 1.8 million. The stock closed at $15.55 on Thursday night. The company on Thursday cut its re-insurance agreements with Beechwood Re following disclosure that regulators that many of Beechwood’s assets did not comply with insurance company guidelines.

best it stocks: StoneMor Partners L.P.(STON)

Advisors’ Opinion:

  • [By Monica Gerson]

    The list of below stocks is notable as the shares have traded on sequentially increasing volume spanning the trading days from September 16 to September 20:

stock market index

William Patalon III

When we first brought graphics chip giant Nvidia Corp. (Nasdaq: NVDA) to your attention back in June 2013, we told you this company was more than just a gaming stock.

It’s a driverless-vehicle stock. It’s an artificial intelligence stock. It’s a virtual reality stock.

It’s a company everybody suddenly wants to partner with.

It’s in all the “right” businesses, which is why there are multiple “triggers” at work here.

And so far, Nvidia has been a home run for investors.

When we first brought this stock to you, we predicted it would double your money in 3.25 years.

It didn’t take anywhere near that long.

This is premium content for Private Briefing subscribers only.

As the executive editor of Money Morning, Bill Patalon has perfected a secret investment strategy that could help you put an extra $125K into your portfolio – this year. To date, Bill has used this strategy to pick 257 winning investments, including 192 double- and triple-digit peak gains. Once you see the secret, you’ll immediately understand why it works so well.

stock market index: Etsy, Inc.(ETSY)

Advisors’ Opinion:

  • [By Jim Swanson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

  • [By Jeremy Bowman]

    Shares of craft-focused internet marketplaceEtsy(NASDAQ:ETSY)stumbled last month, falling 12% according to data from S&P Global Market Intelligenceafter a disappointing fourth-quarter report.

  • [By Brian Withers]

    If investors want to tap into the growing trend of e-commerce and diversify their portfolio beyond Amazon, Shopify (NYSE:SHOP) and Etsy (NASDAQ:ETSY) make the shortlist. Shopify is more a pick-and-shovelplay, as the company hasbuilt a powerful back office platform that essentially enables entrepreneursto run an e-commerce business from their phone. Etsy is a pure play marketplace that focuses on serving the creative entrepreneur. These two companies had similar revenue in 2016, were both started in almost the same year (Etsy 2005, Shopify 2006), and are in the business of helping product-selling entrepreneurs connect to buyers online. Let’s take a deeper dive into these two companies and see which is the better buy.

stock market index: KNOT Offshore Partners LP(KNOP)

Advisors’ Opinion:

  • [By ]

    If I Could Only Choose One…
    Of all the double-digit yielders in my screening universe, Knot Offshore Partners (NYSE: KNOP) has the strongest coverage ratio. The company is currently distributing annual payments of $2.08 per share, and the average earnings estimate for next year is $2.51 per share — for a comfortable coverage ratio of 121% ($2.51/$2.08).

stock market index: Wolverine World Wide, Inc.(WWW)

Advisors’ Opinion:

  • [By Matt Hogan]

    SKX is also highly attractive in a relative basis when compared to several of its publicly traded peers: Foot Locker, Inc. (NYSE: FL), Deckers Outdoor Group (NYSE: DECK), Wolverine World Wide, Inc. (NYSE: WWW) and Columbia Sportswear Company (NASDAQ: COLM). The company's forward EBITDA multiple of 6.9x is equal or below all of the comparable companies: FL (6.9x), DECK (7.6x), WWW (10.1x) and COLM (10.8x).

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session.

    Pier 1 Imports Inc (NYSE: PIR) Dec16 5.0 Puts Sweep: 1191 @ ASK $0.80: 1354 traded vs 102 OI: $5.32 Ref
    Alcoa Inc (NYSE: AA) Jul16 9.5 Puts Sweep: 1494 @ ASK $0.13: 14k traded vs 6682 OI: $10.09 Ref
    Sarepta Therapeutics Inc (NASDAQ: SRPT) Jul16 10.0 Puts: 3536 @ ASK $0.50: 5506 traded vs 54k OI: Earnings 8/4 $22.50 Ref
    Tableau Software Inc (NYSE: DATA) Jul16 47.5 Puts Sweep: 837 @ ASK $0.30: 995 traded vs 37 OI: Earnings 8/3 $50.60 Ref
    Yandex NV (NASDAQ: YNDX) Aug16 18.0 Puts Sweep: 532 @ ASK $0.30: 2143 traded vs 78 OI: Earnings 7/28 Before Open $22.02 Ref
    Wolverine World Wide, Inc. (NYSE: WWW) Aug16 22.5 Puts: 719 @ ASK $1.35: 1032 traded vs 0 OI: Earnings 7/19 $22.22 Ref
    Conn's Inc (NASDAQ: CONN) Jan17 5.0 Puts Sweep: 605 @ ASK $0.85: 1355 traded vs 3132 OI: $7.16 Ref

    Posted-In: Huge Put PurchasesNews Options Markets

stock market index: Boot(h)

Advisors’ Opinion:

  • [By Lee Jackson]

    A10% owner of Hyatt Hotels Corp. (NYSE: H) wasselling some stock this past week. Elsinore Trust parted with a total of 108,815 shares at prices between $52.37 and $53.34. That netted the trust some $2.7 million. The stock closed last Friday at $52.62. The 52-week range for the hotel chain is $44.30 to $58.05, while the consensus price target is $56.44.

stock market index: Lannett Co Inc(LCI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Edwards Lifesciences Corp (NYSE: EW) announced plans to buy Valtech Cardio for $340 million in cash and stock. The company also announced a $1 billion buyback plan.
    Epizyme Inc (NASDAQ: EPZM) disclosed that it has received Fast Track designation for tazemetostat.
    Athene Holding Ltd. (NYSE: ATH) reported that it has priced its 23.8 million share IPO between $38 per share and $42 per share.
    Lannett Company, Inc. (NYSE: LCI) reported the approval for its Metaxalone Tablets USP, 800 mg.

  • [By Ashley Moore]

    We’ve compiled a list of the most heavily shorted stocks to show you which stocks have the most negative sentiment on the market…

    Company Name (Ticker)Short FloatShare PriceHanwha Q Cells Co. Ltd. (Nasdaq ADR: HQCL)98.52%$ 8.88Renren Inc. (NYSE: RENN)91.59%$ 8.53Weight Watchers International Inc. (NYSE: WTW)67.92%$12.57INSYS Therapeutics Inc. (Nasdaq: INSY)66.71%$10.74Twilio Inc. (NYSE: TWLO)66.34%$33.17Nutanix Inc. (Nasdaq: NTNX)65.65%$31.96Fitbit Inc. (NYSE: FIT)55.15%$ 6.06Weibo Corp. (Nasdaq ADR: WB)53.83%$55.26RPC Inc. (NYSE: RES)53.62%$21.19Straight Path Communications Inc. (NYSEMKT: STRP)49.27%$34.79Momo Inc. (Nasdaq ADR: MOMO)48.63%$26.80Seritage Growth Properties (NYSE: SRG)46.91%$44.87Lannett Company Inc. (NYSE: LCI)45.46%$23.00Gogo Inc. (Nasdaq: GOGO)43.98%$ 9.10Altisource Portfolio Solutions SA (Nasdaq: ASPS)42.78%$22.73Cheetah Mobile Inc. (NYSE ADR: CMCM)40.86%$10.00

    Some investors think the only way to profit from the stock market is to buy stocks and wait for the price to rise. However, these investors are missing out on the massive profit opportunity that comes from shorting stocks.

  • [By Peter Graham]

    Small cap generic pharmaceutical stock Lannett Company, Inc (NYSE: LCI) is thesecond most shorted stock on the NYSE with short interest of 55.65% according toHighshortinterest.com. Lannett Company was founded in 1942 anddevelops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications and therapeutic areas. The Company believes its ability to select viable products for development, efficiently develop such products (including obtaining any applicable regulatory approvals), vertically integrateitself into certain specialty markets and achieving economies in production are all critical for its success in the generic pharmaceutical industry in which it operates.

  • [By Peter Graham]

    Small cap generic pharmaceutical stock Lannett Company, Inc (NYSE: LCI) is thethird most shorted stock on the NYSE with short interest of 52.86% according toHighshortinterest.com.Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications and therapeutic areas. The Company believe that its ability to select viable products for development, efficiently develop such products (including obtaining any applicable regulatory approvals), vertically integrateitself into certain specialty markets and achieve economies in production are all critical for its success in the generic pharmaceutical industry in which it operates.

financial investment

Poor Ethereum. As if it didn’t have enough troubles already. Earlier this year, it hard forked to rescue the DAO, only to suffer the ignominy of seeing miners continue to mine the old chain in defiance of clear and explicit guidance from Ethereum developers. But at least that was an intentional fork, though admittedly controversial. Now, it has forked again – unintentionally.

The problem concerns Ethereum’s clients Geth and Parity. At 3 pm on Thursday November 24th, the two clients slipped out of synch. The effect is to create two versions of the Ethereum blockchain – the Geth version and the Parity version. Or two currencies, if you like – Geth and Parity.

So how did this unfortunate bifurcation happen? As ever, Vitalik Buterin’s explanation on Ethereum’s website is in technical jargon:

Summary:  An issue has been identified with Geth’s journaling mechanism. This caused a network fork at block #2686351 (Nov-24-2016 14:12:07 UTC). The new Geth release 1.5.3 fixes the journaling issue and repairs the fork.

financial investment: CYREN Ltd.(CYRN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Cyren Ltd (NASDAQ: CYRN) got a boost, shooting up 41 percent to $2.33 after the company reported a strategic investment from Warburg Pincus Funds.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Tyson Foods, Inc. (NYSE: TSN) is expected to report quarterly earnings at $1.38 per share on revenue of $9.86 billion.
    Aecom (NYSE: ACM) is projected to report quarterly earnings at $0.71 per share on revenue of $4.67 billion.
    JD.Com Inc(ADR) (NASDAQ: JD) is estimated to report quarterly earnings at $0.11 per share on revenue of $12.60 billion.
    58.com Inc (ADR) (NYSE: WUBA) is projected to report quarterly earnings at $0.28 per share on revenue of $383.60 million.
    Kamada Ltd (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $25.00 million.
    Palatin Technologies, Inc. (NYSE: PTN) is projected to report quarterly earnings at $0.06 per share on revenue of $28.00 million.
    TheStreet, Inc. (NASDAQ: TST) is estimated to report a quarterly loss at $0.02 per share on revenue of $15.81 million.
    Atlantica Yield PLC (NASDAQ: ABY) is projected to report quarterly earnings at $0.45 per share on revenue of $290.80 million.
    Asure Software Inc (NASDAQ: ASUR) is estimated to report quarterly earnings at $0.15 per share on revenue of $15.26 million.
    Cyren Ltd (NASDAQ: CYRN) is expected to report quarterly loss at $0.06 per share on revenue of $7.90 million.
    Viewray Inc (NASDAQ: VRAY) is estimated to report quarterly loss at $0.12 per share on revenue of $18.58 million.

     

financial investment: region(DGLD)

Advisors’ Opinion:

  • [By Jim Robertson]

    The VelocityShares 3x Inverse Gold ETN (NASDAQ: DGLD) seeks to provideshort exposure to three times (3x) the daily performance of theS&P GSCI Gold Index. As with UGLD, DGLD would be doing this viafutures contracts.

financial investment: KNOT Offshore Partners LP(KNOP)

Advisors’ Opinion:

  • [By ]

    If I Could Only Choose One…
    Of all the double-digit yielders in my screening universe, Knot Offshore Partners (NYSE: KNOP) has the strongest coverage ratio. The company is currently distributing annual payments of $2.08 per share, and the average earnings estimate for next year is $2.51 per share — for a comfortable coverage ratio of 121% ($2.51/$2.08).

financial investment: QuickLogic Corporation(QUIK)

Advisors’ Opinion:

  • [By Alex McGuire]

    These are the 10 best penny stocks that have seen the biggest returns over the last week (March 7 – March 14)…

    Penny StockCurrent PriceWeekly Gain (March 7 – March 14)Ocera Therapeutics Inc. (Nasdaq: OCRX)$1.47+147.1%Internap Corp. (Nasdaq: INAP)$3.28+41.4%Soligenix Inc. (Nasdaq: SNGX)$2.94+40%Navios Maritime Partners LP (NYSE: NMM)$2.63+37%QuickLogic Corp. (Nasdaq: QUIK)$2.14+30.5%Adamis Pharmaceuticals Corp. (Nasdaq: ADMP)$4.60+22.7EXCO Resources Inc. (NYSE: XCO)$0.65+20.5%Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC)$4.38+20.3%Hebron Technology Co. Ltd. (Nasdaq: HEBT)$3.99+19.1%Curis Inc. (Nasdaq: CRIS)$2.85+18.4%

    As a reminder, this is only a tracking metric of penny stocks trading on SEC-regulated exchanges like the Nasdaq and NYSE. Although these top penny stocks are safer than those trading on the pink sheets, we don’t recommend buying any of them without the proper amount of financial research.

  • [By Lisa Levin]

    QuickLogic Corporation (NASDAQ: QUIK) was down, falling around 10 percent to $2.10. QuickLogic reported a $15 million share offering.

    Commodities

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston
  • [By Lisa Levin]

    Thursday afternoon, the information technology sector proved to be a source of strength for the market. Leading the sector was strength from QuickLogic Corporation (NASDAQ: QUIK) and Veeco Instruments Inc. (NASDAQ: VECO).

financial investment: CIENA Corporation(CIEN)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wednesday was a mixed day for the stock market, with the Dow Jones Industrials falling while the Nasdaq Composite posted modest gains. Parts of the market reacted differently to conflicting news items, which included both poor performance in the energy market and signs of promise for the economy more broadly. Despite the conflict among industry sectors, some stocks got hit particularly hard, and Rite Aid (NYSE:RAD), Ciena (NYSE:CIEN), and Express (NYSE:EXPR) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Lisa Levin]

    Ciena Corporation (NYSE: CIEN) posted downbeat earnings for its fourth quarter.

    Ciena posted Q4 adjusted earnings of $0.44 per share on revenue of $716.2 million. Analysts were expecting earnings of $0.46 per share on revenue of $716.5 million.

  • [By Rich Smith]

    Shares of communications equipment supplier Ciena Corporation (NYSE:CIEN) slumped more than 10% in early-morning trading on Wednesday before climbing back to “only” an 8.8% loss as of 3:15 p.m. EST.

  • [By Lee Jackson]

    Ciena Corp. (NYSE: CIEN) is another tech company that saw insider selling last week. The president and CEO of the optical giant, Gary Smith, sold a reported 114,318 shares at $24.67 per share. The total for the trade was set at a solid $2,820,225. Shares closed last Friday at $24.41, in a 52-week range of $15.62 to $25.19. The consensus price target is $28.36.

  • [By Trey Thoelcke]

    Ciena Corp. (NYSE: CIEN) will report its most recent quarterly results Thursday morning. The consensus estimates call for EPS of $0.49 and $726.84 million in revenue. Shares closed at $23.87 on Friday, in a 52-week range of $18.94 to $27.98. The consensus price target is $30.77.

financial investment: Silver Bay Realty Trust Corp.(SBY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Silver Bay Realty Trust Corp (NYSE: SBY) got a boost, shooting up 18 percent to $21.47. Tricon Capital Group Inc. announced plans to buy Silver Bay Realty Trust for $21.50 per share.

  • [By Mark Holder]

    Instead of competing in one-off auctions, the traditional method of acquiring homes and the one preferred by Silver Bay Realty Trust (NYSE: SBY  ) (NYSE: SBY  ) (NYSE: SBY  ) and American Homes 4 Rent (NYSE: AMH  ) (NYSE: AMH  ) (NYSE: AMH  ) , the company is obtaining non-performing loans in pools that include thousands of loans. The ultimate outcome of these different models is unknown, but the market hasso far supported Altisource Residential.